Pandit-Taskar N - Search Results

1

¹⁸F-FDG PET/CT for Posttreatment Surveillance Imaging of Patients with Stage III Merkel Cell Carcinoma.

Mahajan S, Barker CA, Mauguen A, D'Angelo SP, Yeh R, Pandit-Taskar N. Mahajan S, et al. J Nucl Med. 2022 Jun;63(6):906-911. doi: 10.2967/jnumed.121.262882. Epub 2021 Oct 7. J Nucl Med. 2022. PMID: 34620729 Free PMC article.

2

Feasibility of safe outpatient treatment in pediatric patients following intraventricular radioimmunotherapy with 131I-omburtamab for leptomeningeal disease.

Prasad K, Serencsits BE, Chu BP, Dauer LT, Donzelli M, Basu E, Kramer K, Pandit-Taskar N. Prasad K, et al. Res Sq [Preprint]. 2024 Feb 28:rs.3.rs-3969388. doi: 10.21203/rs.3.rs-3969388/v1. Res Sq. 2024. Update in: EJNMMI Res. 2024 Jul 31;14(1):70. doi: 10.1186/s13550-024-01127-0. PMID: 38464207 Free PMC article. Updated. Preprint.

3

Molecular imaging in nuclear cardiology.

Strauss HW, Grewal RK, Pandit-Taskar N. Strauss HW, et al. Semin Nucl Med. 2004 Jan;34(1):47-55. doi: 10.1053/j.semnuclmed.2003.09.006. Semin Nucl Med. 2004. PMID: 14735458 Review.

4

Radiopharmaceutical therapy for palliation of bone pain from osseous metastases.

Pandit-Taskar N, Batraki M, Divgi CR. Pandit-Taskar N, et al. J Nucl Med. 2004 Aug;45(8):1358-65. J Nucl Med. 2004. PMID: 15299062 Free article. Review.

5

Clinical significance of unexplained abnormal focal FDG uptake in the abdomen during whole-body PET.

Pandit-Taskar N, Schöder H, Gonen M, Larson SM, Yeung HW. Pandit-Taskar N, et al. AJR Am J Roentgenol. 2004 Oct;183(4):1143-7. doi: 10.2214/ajr.183.4.1831143. AJR Am J Roentgenol. 2004. PMID: 15385321

6

Oncologic imaging in gynecologic malignancies.

Pandit-Taskar N. Pandit-Taskar N. J Nucl Med. 2005 Nov;46(11):1842-50. J Nucl Med. 2005. PMID: 16269598 Free article. Review.

7

Organ and fetal absorbed dose estimates from 99mTc-sulfur colloid lymphoscintigraphy and sentinel node localization in breast cancer patients.

Pandit-Taskar N, Dauer LT, Montgomery L, St Germain J, Zanzonico PB, Divgi CR. Pandit-Taskar N, et al. J Nucl Med. 2006 Jul;47(7):1202-8. J Nucl Med. 2006. PMID: 16818956 Free article.

8

The utility of F-18 fluorodeoxyglucose whole body PET imaging for determining malignancy in cystic lesions of the pancreas.

Mansour JC, Schwartz L, Pandit-Taskar N, D'Angelica M, Fong Y, Larson SM, Brennan MF, Allen PJ. Mansour JC, et al. J Gastrointest Surg. 2006 Dec;10(10):1354-60. doi: 10.1016/j.gassur.2006.08.002. J Gastrointest Surg. 2006. PMID: 17175454

9

Preoperative characterisation of clear-cell renal carcinoma using iodine-124-labelled antibody chimeric G250 (124I-cG250) and PET in patients with renal masses: a phase I trial.

Divgi CR, Pandit-Taskar N, Jungbluth AA, Reuter VE, Gönen M, Ruan S, Pierre C, Nagel A, Pryma DA, Humm J, Larson SM, Old LJ, Russo P. Divgi CR, et al. Lancet Oncol. 2007 Apr;8(4):304-10. doi: 10.1016/S1470-2045(07)70044-X. Lancet Oncol. 2007. PMID: 17395103 Clinical Trial.

10

Antibody mass escalation study in patients with castration-resistant prostate cancer using 111In-J591: lesion detectability and dosimetric projections for 90Y radioimmunotherapy.

Pandit-Taskar N, O'Donoghue JA, Morris MJ, Wills EA, Schwartz LH, Gonen M, Scher HI, Larson SM, Divgi CR. Pandit-Taskar N, et al. J Nucl Med. 2008 Jul;49(7):1066-74. doi: 10.2967/jnumed.107.049502. Epub 2008 Jun 13. J Nucl Med. 2008. PMID: 18552139 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

178 results

Search Page

Filters